Trim BKNG to 0.65-0.75x benchmark weight at ~$157.50; hedge to $145 Dec puts
Trim BKNG to 0.65-0.75x benchmark weight at market near $157.50 (25-35% reduction from current UW tilt), front-loaded per the 9/28 lesson. Reject Research Manager's Overweight, Trader's BUY at $157.50, Conservative Analyst's 1.5-2% starter, and Neutral Analyst's "execute as written" — all constitute adding into breakdown at a configuration the 9/23 binding lesson explicitly invalidates. Shift hedge to 3-4% notional in $145 puts (Dec expiry). Hard inversion at $148.50 on volume >8M shares escalates to 0.55-0.65x. Re-engage at 1.0x only on Q3 beat-and-raise with forward EPS >$12.50 and no Muse concerns.
| Position | Action |
|---|---|
| Execute at market near $157.50, front-loaded | Trim to 0.65-0.75x benchmark weight (~25-35% reduction from current UW tilt) |
| Confirmed close below $148.50 on volume >8M shares | Escalate to 0.55-0.65x magnitude |
| Q3 beat-and-raise with forward EPS >$12.50 and no incremental Muse commentary | Re-engage to 1.0x benchmark weight |
BKNG presents a generational buying opportunity as a high-quality compounder (87% gross margins, 34% operating margins, 20%+ ROA) trading at distressed multiples while returning massive capital to shareholders.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $162.40 | bearish |
| close_50_sma | $188.89 | bearish |
| close_200_sma | $181.56 | bearish |
| rsi | 29.91 | bearish |
| macd | -8.45 (line) / -8.61 (signal) / +0.15 (histogram) | bearish |
| boll | Mid $166.70 / Upper $180.33 / Lower $153.06 | bearish |
| vwma | $163.61 | bearish |
| atr | $5.93 | neutral |
Support: 153.06 · 154.06 · 158.33 | Resistance: 162.4 · 166.7 · 180.33 · 181.56 · 188.89
BKNG is in a confirmed downtrend with price at $158.33 (Oct-05 close) trading well below both the 50-day SMA ($188.89) and 200-day SMA ($181.56), with a death cross now in effect. The stock shows deeply oversold conditions with RSI at 29.91 (low of 21.46 on Sep-23), and early counter-trend signals are emerging including a positive MACD histogram (+0.15) and bullish divergence. VWMA at $163.61 confirms high-volume distribution. Critical support sits at $153.06 (lower Bollinger Band), with immediate resistance at $162.40 (10 EMA). The recommended stance is HOLD for existing holders while awaiting a confirmed reversal structure.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 beat-and-raise with forward EPS >$12.50 and no incremental Muse commentary
Then: Return to 1.0x benchmark weight
EV: upside · concedes: Bear's technical framework is accurate about current tape conditions (death cross, RSI, price below moving averages); Multiple compression has already occurred; EU DMA regulation is a legitimate multi-year risk; VWMA declining in lockstep with price is factually accurate
BKNG's attractive valuation metrics are a warning sign, not a buying opportunity—the market is correctly pricing in decelerating revenue growth, unsustainable buyback-driven EPS engineering, multiple compression in a Fed-on-hold environment, and a brutal Q3 comparable against a record quarter, making the risk/reward asymmetric to the downside for new capital.
· concedes: Forward P/E of 12.81x and PEG of 0.87 are technically cheap by historical standards and would represent a buying opportunity IF the forward EPS estimates prove accurate; Buybacks are actively occurring and providing mechanical price support in the near term; Technical indicators show early-stage counter-trend signals that COULD develop into a reversal if confirmed
→ vs conservative: Technical analyst's 10 EMA reclaim rule costs 3.2% per share premium ($162.40 vs $157.50 entry) and sacrifices ~10 basis points of alpha on 3% portfolio weight; waiting for confirmation often means buying the middle of the move, not the bottom
→ vs conservative: Death cross is among the most well-documented lagging indicators in market history; using a backward-looking technical signal to argue against a 12.8x forward P/E stock with 0.87 PEG ratio is comparing two completely different analytical frameworks
→ vs conservative: Bollinger middle band at $166.70 target only requires partial mean reversion to deliver $9.20 upside versus $8 downside - already better than 1:1 before any meaningful recovery
→ vs neutral: Neutral 5.0 with low confidence based on no data is permission to act on fundamentals, not a reason to sit out; no competing narratives means no narrative risk and higher edge for fundamental buyers
→ vs neutral: Q2 showed revenue up 8.1% and net income up 117% year-over-year; if sentiment has nothing to push back against the buy thesis, waiting contradicts the data
→ vs conservative: Macro analyst's HOLD contradicts own data: 96% zero Fed cuts + 8% recession = soft landing structurally supportive for consumer discretionary; cited Barron's contrarian piece and intraday sector strength as own evidence turning supportive
→ vs conservative: Forward P/E of 12.81x is not elevated - it's a discount to S&P 500 and below BKNG's historical forward multiple; PEG of 0.87 below 1.0 by no metric constitutes a premium valuation
→ vs neutral: HOLD stance is implicitly short volatility and short mean reversion, which is riskier than people realize when framed as 'cautious'
Market Cap
$118.97B
TTM PE Ratio
17.55x
Forward PE
12.81x
PEG Ratio
0.87
Price-to-Book
-11.13x
EPS (TTM)
$9.02
Forward EPS
$12.36
Dividend Yield
1.06%
Beta
1.128
52-Week High
$224.99
52-Week Low
$150.14
50-Day MA
$189.59
200-Day MA
$182.64
Revenue (TTM)
$28.24B
Gross Profit
$24.63B
Gross Margin
87.2%
EBITDA
$10.41B
EBITDA Margin
36.9%
Net Income
$7.21B
Net Margin
25.5%
Operating Margin
34.4%
Return on Assets (ROA)
20.4%
Free Cash Flow (TTM)
$7.73B
FCF Yield
~6.5%
Cash & Equivalents
$17.21B
Receivables
$4.34B
Goodwill & Intangibles
$3.52B
Total Assets
$29.68B
Total Debt
$20.69B
Net Debt
$2.97B
Stockholders' Equity
-$10.78B
Treasury Stock
$62.13B
Retained Earnings
$43.05B
Current Ratio
1.09
Working Capital
$1.99B
Q1 2026 Revenue
$5.53B
Q1 2026 Net Income
$1.08B
Q1 2026 EPS
$1.36
Q2 2026 Revenue
$7.35B
Q2 2026 Net Income
$1.95B
Q2 2026 EPS
$2.53
Q2 2026 EBITDA
$3.02B
Q3 2025 Revenue
$9.01B
Q4 2025 Revenue
$6.35B
Q2 2026 Operating CF
$3.72B
Q2 2026 FCF
$3.64B
Q1 2026 Operating CF
$3.22B
Q1 2026 FCF
$3.11B
Q2 2026 Selling & Marketing
$3.31B
Q2 2026 G&A
$1.12B
Q2 2026 Salaries & Wages
$900M
Q2 2026 Total OpEx
$4.85B
Q2 2026 Tax Rate
23.8%
Q2 2026 Interest Expense
$300M
Capex (Quarterly)
~$70-100M
Shares Outstanding (Q2 2026)
758M
Shares Outstanding (Q1 2025)
821M
Share Count Reduction (6Q)
-7.6%
H1 2026 Buybacks
$7.76B
H1 2026 Dividends
$664M
Total H1 2026 Capital Return
~$8.4B
Strengths
Concerns
BUY
Macro: The prediction-market data paints a clear late-cycle soft-landing picture: 96% probability of zero Fed rate cuts in 2026 (down ~1.1pp WoW, $8.8M volume), 0% probability of 6+ Fed cuts, US recession probability at 8% (down ~1pp WoW), UK recession at 7%, and Japan recession at 4%. The weak September jobs report pushed gold up and cut rate-cut expectations lower — the market is pricing an economy weak enough to keep the Fed on hold but not weak enough to break. Cross-asset signals show Nasdaq at fresh highs while Dow slipped, tech leadership with cyclical lag, and consumer stocks stabilizing with Barron's calling a contrarian buy. FRED macro series (CPI, fed funds, 10Y, unemployment) were unavailable in this run. Net: a higher-for-longer Fed with no cuts, soft but not cracking labor market — historically a constructive backdrop for travel & leisure.
↩ rebuts: “Bull's characterization of RSI divergence, ATR compression, and Bollinger Band test as 'classic bottoming pattern'”
↩ rebuts: “Bull's characterization of RSI divergence, ATR compression, and Bollinger Band test as 'classic bottoming pattern'”